Congenital myopathy – Basic Information

Go back

Congenital myopathy is a rare group of genetic muscle disorders that affect how muscles develop and function, typically appearing at or shortly after birth and causing muscle weakness and reduced muscle tone throughout the body.

Understanding Congenital Myopathy

Congenital myopathy represents a collection of genetic conditions that primarily affect skeletal muscle fibers, causing problems with muscle strength and tone. The term “congenital” means present at birth, while “myopathy” refers to disease of the muscle. These disorders occur when genetic changes affect the proteins and structures necessary for muscles to work properly. Unlike some other muscle conditions, congenital myopathies typically do not cause muscle fibers to die and regenerate repeatedly. Instead, they prevent muscles from developing or functioning correctly from the start.[1]

What makes congenital myopathies particularly challenging is that they display what doctors call pleiotropy (one genetic change causing multiple effects) and genetic heterogeneity (different genetic changes causing similar symptoms). This means that different children with mutations in the same gene might have very different experiences, while children with mutations in completely different genes might show remarkably similar symptoms. More than 40 types of congenital myopathies have been identified, involving over 30 different causative genes.[6]

These conditions affect approximately 6 in every 100,000 live births worldwide, making them relatively uncommon but significant contributors to childhood muscle weakness and disability.[8]

Epidemiology and Who Is Affected

Congenital myopathies are rare inherited disorders that can affect people of any background, ethnicity, or geographic location. The conditions occur in approximately 6 per 100,000 live births globally, though exact numbers may vary by region due to differences in diagnostic capabilities and reporting systems.[8]

Most types of congenital myopathy affect males and females equally, with one notable exception. Myotubular myopathy, which is linked to mutations in the MTM1 gene, typically affects only male babies because this gene is located on the X chromosome. Males have only one X chromosome, so a single mutation in this gene causes the disease, while females usually have a second normal copy that protects them from severe symptoms.[1]

The severity and age when symptoms first appear can vary widely, even within the same family. Some babies show signs of muscle weakness immediately at birth or even before birth, with mothers noticing reduced fetal movements during pregnancy. Other children may not show obvious symptoms until they are several months old or even during early childhood, when parents notice they are slower to reach developmental milestones like sitting up, crawling, or walking.[2]

Causes and Genetic Origins

Congenital myopathies are caused by genetic mutations, which are permanent changes in the DNA instructions that tell the body how to build and maintain muscles. These genetic changes are inherited from parents or, less commonly, occur spontaneously in the affected individual without any family history.[1]

The mutations affect genes that code for proteins essential to muscle structure and function. For example, mutations in the RYR1 gene, which provides instructions for making a protein that helps muscles contract and relax, are responsible for central core disease and some forms of multicore disease. Similarly, mutations in genes like NEM2, ACTA1, and TPM2 cause nemaline myopathy by disrupting the thin filaments that are part of the muscle’s contractile machinery.[1]

Different types of congenital myopathy are associated with specific genes. Central core disease is most commonly caused by mutations in the RYR1 gene. Nemaline myopathy can result from mutations in one of several genes, including NEM2, ACTA1, and TPM2. Centronuclear myopathy is linked to mutations in the DNM2, BIN1, or RYR1 genes. Myotubular myopathy, the severe form affecting mainly boys, is caused by mutations in the MTM1 gene.[1]

The inheritance patterns vary by type. Some congenital myopathies follow an autosomal dominant pattern, meaning a child needs to inherit only one mutated copy of the gene from one parent to develop the condition. Others follow an autosomal recessive pattern, requiring two mutated copies, one from each parent. In recessive conditions, parents are typically carriers who do not show symptoms themselves but each carry one mutated gene.[5]

Risk Factors

The primary risk factor for congenital myopathy is having a family history of the condition. Since these disorders are genetic, children born to parents who carry mutations in the relevant genes face an increased risk. If one or both parents have a personal or family history of muscle weakness, delayed motor development, or diagnosed congenital myopathy, their children may be at higher risk.[1]

In cases of autosomal recessive inheritance, both parents must be carriers for a child to develop the condition. Each pregnancy with two carrier parents has a 25% chance of producing an affected child, a 50% chance of producing a carrier child, and a 25% chance of producing a child who neither has the condition nor is a carrier. For autosomal dominant conditions, an affected parent has a 50% chance of passing the mutation to each child.[5]

For myotubular myopathy specifically, being male is the primary risk factor because the condition is X-linked. Females who carry the mutation on one of their X chromosomes are usually unaffected because their second X chromosome has a normal copy of the gene. However, they can pass the mutated gene to their sons, who will develop the severe form of the disease.[1]

There are no known lifestyle, environmental, or behavioral factors that increase the risk of congenital myopathy. These conditions result purely from genetic changes and cannot be caused by anything parents did or did not do during pregnancy or before conception.

Symptoms and How They Affect Daily Life

The symptoms of congenital myopathy vary depending on the specific type and severity but share common features that affect how the body moves and functions. The most characteristic symptom is hypotonia, often described as “floppiness.” Babies with hypotonia have reduced muscle tone, meaning their muscles feel soft and loose rather than firm. This makes them appear limp when held, and they may have difficulty holding their heads up or maintaining postures that other babies their age can manage.[1]

Muscle weakness is another central feature. This weakness typically affects certain muscle groups more than others, particularly the muscles of the neck, shoulders, and pelvis. In medical terms, this is called proximal muscle weakness because it affects muscles closer to the center of the body. The hands and feet are usually less affected, though there are exceptions. This pattern of weakness makes it difficult for affected children to perform activities that require lifting their arms, climbing stairs, or rising from a sitting or lying position.[1]

Breathing difficulties are common and can be life-threatening, especially in severe forms. The muscles responsible for breathing, including the diaphragm and muscles between the ribs, may be weak. This can lead to shallow breathing, difficulty clearing secretions from the lungs, and increased risk of respiratory infections like pneumonia. Some infants require breathing support from birth, while others develop breathing problems gradually over time.[2]

Feeding problems affect many babies with congenital myopathy. Weak muscles in the face, mouth, and throat make it difficult to suck, chew, and swallow. Babies may tire easily during feeding, take a long time to finish meals, or choke frequently. Poor feeding can lead to inadequate nutrition and slow weight gain, which is particularly concerning during the critical growth period of infancy.[1]

Skeletal problems develop in many children as a consequence of muscle weakness. Scoliosis, an abnormal sideways curve of the spine, is particularly common. When the muscles that normally support the spine are weak, the spine may gradually curve as the child grows. Other skeletal issues include hip problems, high-arched palate, and foot deformities. Weak bones, a condition called osteopenia, can occur especially in myotubular myopathy because normal muscle activity is needed to keep bones strong.[1]

Facial features can be distinctive in some children. Weakness of facial muscles may create an elongated face with limited facial expressions, sometimes called a “myopathic facies.” Droopy eyelids and difficulty moving the eyes from side to side or up and down may occur in certain types, particularly centronuclear myopathy. These eye problems can cause double vision or difficulty focusing on objects.[7]

Delayed motor milestones are a hallmark of congenital myopathy. Affected children typically take longer than their peers to achieve developmental goals like rolling over, sitting without support, crawling, standing, and walking. Some children eventually learn to walk but may have an unusual gait, tire easily, or require assistive devices. Others may never achieve independent walking and need wheelchairs or other mobility aids.[2]

⚠️ Important
In most cases of congenital myopathy, intelligence and cognitive function remain normal. The brain itself is usually not affected by these conditions, which primarily target skeletal muscles. This means that despite significant physical challenges, many individuals with congenital myopathy have normal learning abilities and can participate fully in educational and social activities appropriate to their age.

Prevention Strategies

Because congenital myopathies are genetic disorders caused by inherited or spontaneous mutations, they cannot be prevented in the traditional sense through lifestyle modifications, vaccinations, or environmental changes. However, families can take several steps to understand their risks and make informed decisions about family planning.[1]

Genetic counseling is valuable for families with a history of congenital myopathy or unexplained muscle weakness. A genetic counselor can help families understand inheritance patterns, assess the risk of having an affected child, and discuss available options. This is particularly important when one parent has a congenital myopathy or when parents have already had one affected child and are considering future pregnancies.[6]

Prenatal testing is available for families at known risk. Tests such as amniocentesis (sampling fluid from around the baby) or chorionic villus sampling (sampling cells from the placenta) can be performed during pregnancy to test the developing baby for known genetic mutations. These procedures carry small risks and are typically offered only when there is a clear family history or when previous genetic testing has identified the specific mutation causing the condition in the family.[8]

For families with a known genetic mutation causing congenital myopathy, preimplantation genetic diagnosis is an option. This technique involves creating embryos through in vitro fertilization, testing them for the genetic mutation before implantation, and transferring only unaffected embryos to the uterus. This approach allows families to have biological children while avoiding the transmission of the genetic condition.[6]

Early detection, while not prevention, can significantly improve outcomes. When a family knows they are at risk or when a healthcare provider recognizes early signs during pregnancy or shortly after birth, preparations can be made for specialized care immediately after delivery. This might include having respiratory support equipment ready or arranging for the baby to be born at a hospital with neonatal intensive care capabilities.[13]

Pathophysiology: How Congenital Myopathies Affect the Body

To understand how congenital myopathies affect the body, it helps to know how muscles normally work. Skeletal muscles are made up of long fibers that contain specialized structures responsible for contraction. When muscles receive signals from nerves, proteins within the muscle fibers slide past each other, shortening the muscle and creating movement. This process requires precise coordination of many different proteins and cellular structures.[6]

In congenital myopathies, genetic mutations disrupt one or more components of this complex machinery. The specific malfunction depends on which gene is mutated and which protein is consequently abnormal or absent. Researchers categorize these problems into several main pathways of muscle function that go wrong.[6]

One major category involves problems with excitation-contraction coupling and structures called triads. This refers to the process by which an electrical signal traveling along a nerve converts into a chemical signal that triggers muscle contraction. The RYR1 gene, commonly mutated in core myopathies, produces a protein that releases calcium inside muscle cells. Calcium is essential for muscle contraction. When this protein does not work correctly, the muscle cannot contract properly, leading to weakness. The MTM1 gene, mutated in myotubular myopathy, and the BIN1 and DNM2 genes affect how cellular structures organize and how signals move within the cell.[6]

Another category involves the actual contraction machinery itself, specifically how actin and myosin proteins interact. These are the proteins that slide past each other to create muscle shortening. Genes like NEB, ACTA1, TNNT1, TPM2, and TPM3 provide instructions for proteins that make up or regulate these sliding filaments. When these proteins are abnormal, the basic mechanism of contraction is impaired. This explains why mutations in these genes cause nemaline myopathy, where rod-like structures accumulate in muscle fibers, representing misassembled or excess protein components.[6]

The characteristic appearance of muscle tissue under a microscope helps doctors classify different types of congenital myopathy. In central core disease, the center of muscle fibers shows regions that lack certain enzymes involved in energy production. In nemaline myopathy, small rod-shaped structures accumulate within muscle fibers. In centronuclear myopathy, the nucleus of muscle cells, which normally sits at the edge of the fiber, is positioned in the center instead. These structural abnormalities result from the underlying genetic and protein problems.[5]

An important concept in congenital myopathies is that the muscles do not usually undergo the repeated cycles of damage and repair seen in other muscle conditions like muscular dystrophy. Instead, the muscle fibers are present but structurally abnormal from the beginning, preventing them from generating normal force. This is why congenital myopathies are often described as non-progressive or slowly progressive. The abnormality exists from birth, and while children may get relatively stronger as they grow and learn to use their muscles more efficiently, the underlying structural problem remains.[3]

The breathing difficulties seen in congenital myopathy result from weakness of the diaphragm and other respiratory muscles. Normal breathing depends on these muscles expanding the chest cavity to draw air into the lungs. When these muscles are weak, each breath brings in less air, reducing oxygen levels in the blood. Over time, this can lead to a buildup of carbon dioxide, which can cause morning headaches, poor sleep quality, and daytime fatigue. Respiratory infections become dangerous because weak muscles cannot generate the forceful cough needed to clear mucus from the lungs.[13]

Skeletal problems develop as a secondary consequence of muscle weakness. Muscles and bones work together as a system. Muscles pull on bones to create movement, but they also provide constant tension that helps bones grow straight and strong. When muscles are weak throughout childhood, this constant tension is reduced. The spine, which normally maintains its shape partly through balanced muscle forces on both sides, may curve to one side, causing scoliosis. Similarly, bones may become thin and fragile because they are not subjected to the normal stresses that stimulate bone strengthening.[13]

⚠️ Important
People with central core disease face a unique risk called malignant hyperthermia during surgery. The same genetic mutation that causes their muscle weakness makes them vulnerable to a dangerous reaction to certain anesthesia medications. During this reaction, muscles throughout the body contract uncontrollably, producing dangerous amounts of heat and potentially fatal complications. Before any surgery, individuals with central core disease or family members of affected individuals must inform their medical team about this risk so alternative anesthesia medications can be used.

Ongoing Clinical Trials on Congenital myopathy

  • A study to evaluate the safety and effectiveness of surlorian in adults with RYR1-related myopathy

    Recruiting

    2 1
    Investigated diseases:
    France Germany The Netherlands Spain
  • Study of ASP2957 Gene Therapy for Male Patients with X-linked Myotubular Myopathy Who Require Breathing Support with Ventilators

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Salbutamol for Improving Muscle Strength in Patients with Congenital Myopathy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

References

https://my.clevelandclinic.org/health/diseases/22392-congenital-myopathy

https://www.ninds.nih.gov/health-information/disorders/congenital-myopathy

https://www.mda.org/disease/congenital-myopathies

https://www.childrens.com/specialties-services/conditions/congenital-myopathy

https://www.merckmanuals.com/professional/pediatrics/inherited-muscular-disorders/congenital-myopathies

https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05626-5

https://www.brainfacts.org/diseases-and-disorders/neurological-disorders-az/diseases-a-to-z-from-ninds/congenital-myopathy

https://en.wikipedia.org/wiki/Congenital_myopathy

https://emedicine.medscape.com/article/1175852-treatment

https://my.clevelandclinic.org/health/diseases/22392-congenital-myopathy

https://www.ninds.nih.gov/health-information/disorders/congenital-myopathy

https://www.mda.org/disease/congenital-myopathies/medical-management

https://pmc.ncbi.nlm.nih.gov/articles/PMC5234865/

https://www.childrens.com/specialties-services/conditions/congenital-myopathy

https://buildingstrength.org/community/resources-support/

https://my.clevelandclinic.org/health/diseases/22392-congenital-myopathy

https://www.childneurologyfoundation.org/disorder/congenital-myopathies/

https://www.ninds.nih.gov/health-information/disorders/congenital-myopathy

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can congenital myopathy be cured?

Currently, there is no cure for any type of congenital myopathy. Treatment focuses on managing symptoms and supporting function through physical therapy, respiratory support, nutritional assistance, and orthopedic interventions. However, research into gene therapy and other targeted treatments is ongoing and shows promise for certain types.

Will my child with congenital myopathy have a normal lifespan?

Life expectancy varies greatly depending on the type and severity of congenital myopathy. Some forms, like severe myotubular myopathy, may result in early death due to respiratory complications, with many children not surviving their first year. Other types, like central core disease, typically allow for normal or near-normal life expectancy with appropriate care and management of complications.

How is congenital myopathy diagnosed?

Diagnosis typically involves a combination of clinical examination showing characteristic patterns of muscle weakness, blood tests that may show normal or slightly elevated creatine kinase levels, genetic testing to identify specific mutations, and sometimes muscle biopsy to examine muscle tissue under a microscope. Genetic testing has become increasingly important and can often provide a definitive diagnosis without the need for biopsy.

Will my child with congenital myopathy be able to walk?

Walking ability varies widely depending on the specific type and severity of the condition. Many children with milder forms eventually learn to walk independently, though they may reach this milestone later than their peers and may tire easily. Children with more severe forms may require wheelchairs or other mobility aids. Physical therapy can help maximize whatever walking ability is possible.

Does congenital myopathy affect intelligence or thinking abilities?

In most cases, congenital myopathy does not affect intelligence or cognitive abilities. The brain is typically unaffected, and individuals usually have normal learning capacity and can participate fully in age-appropriate educational activities. The condition primarily affects skeletal muscles rather than the central nervous system.

🎯 Key takeaways

  • Congenital myopathy comprises more than 40 different types caused by mutations in over 30 genes, making genetic diagnosis complex but increasingly important for treatment planning.
  • Unlike muscular dystrophy, most congenital myopathies are non-progressive or slowly progressive because muscles don’t repeatedly break down and regenerate but are structurally abnormal from the start.
  • The same genetic mutation can cause dramatically different severity levels even within the same family, a phenomenon called pleiotropy that makes predicting outcomes challenging.
  • Respiratory complications pose the greatest risk to life in severe congenital myopathies, but modern ventilatory support has significantly improved survival rates and quality of life.
  • People with central core disease must inform their healthcare providers before any surgery because they risk malignant hyperthermia from certain anesthesia medications.
  • Intelligence typically remains completely normal in congenital myopathy, allowing affected individuals to pursue education and careers despite physical limitations.
  • Some children actually gain relative strength over time as they learn compensatory strategies and their bodies grow, even though the underlying muscle abnormality persists.
  • Gene therapy research shows particular promise for MTM1-related myotubular myopathy and BIN1-related centronuclear myopathy, potentially offering future treatment options.

Connected medications: